Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.

Aims Chronic heart failure (CHF) is frequently associated with a decreased haemoglobin level, whereas the mechanism remains largely unknown. Methods and results One hundred consecutive CHF patients without anaemia or renal dysfunction based on non-cardiac reasons were enrolled. We explored determinants of anaemia (as iron parameters, erythropoietin, hepcidin and kidney function) including red cell volume (RCV) (by a 51 Cr assay) as well as related markers and plasma volume. The influence of each factor on haemoglobin concentrations was determined in a multiple regression model. Mean haemoglobin concentrations were 11.7 +/- 0.8 mg/dL in anaemic CHF patients and 14.4 +/- 1.2 mg/dL in non-anaemic patients. Corrected reticulocytes were lower in anaemic patients (35.1 +/- 15.7 vs. 50.3 +/- 19.2 G/L, P = 0.001), but the RCV was not reduced (1659.3 +/- 517.6 vs. 1826.4 +/- 641.3 mL, P = 0.194). We found that plasma volumes were significantly higher in anaemic CHF patients (70.0 +/- 2.4 vs. 65.0 +/- 4.0%, P < 0.001). Plasma volume was the best predictor of haemoglobin concentrations in the regression model applied (B = -0.651, P < 0.001, R(2) = 0.769). Conclusion Haemodilution appears to be the most potent factor for the development of low haemoglobin levels in patients with CHF. Our data support an additional independent, but minor influence of iron deficiency on haemoglobin concentrations in CHF patients.

[1]  M. Ochiai,et al.  [Anemia in patients with advanced heart failure]. , 2010, Arquivos brasileiros de cardiologia.

[2]  N. Levin,et al.  Iron and anemia in human biology: a review of mechanisms , 2008, Heart Failure Reviews.

[3]  D. J. Veldhuisen,et al.  Is anemia in chronic heart failure caused by iron deficiency? , 2007, Journal of the American College of Cardiology.

[4]  W. Stremmel,et al.  The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. , 2007, Endocrinology.

[5]  D. Swinkels,et al.  Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. , 2007, Clinical chemistry.

[6]  R. Foxall,et al.  Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women , 2007, British Journal of Nutrition.

[7]  M. Komajda.  Anemia in chronic heart failure: should we treat it and how? , 2007, Journal of the American College of Cardiology.

[8]  L. Rohde,et al.  Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia. , 2007, Journal of cardiac failure.

[9]  J. McMurray,et al.  Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial , 2007, European journal of heart failure.

[10]  G. Navis,et al.  Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. , 2006, European heart journal.

[11]  D. Karageorgopoulos,et al.  Etiology of anemia in patients with advanced heart failure. , 2006, Journal of the American College of Cardiology.

[12]  N. Andrews,et al.  Interleukin-6 induces hepcidin expression through STAT3. , 2006, Blood.

[13]  J. Struck,et al.  Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure , 2006, European journal of clinical investigation.

[14]  A. Bolger,et al.  Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. , 2006, Journal of the American College of Cardiology.

[15]  A. Swaak.  Anemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis, and the effect of treatment on disease activity. , 2006, The Journal of rheumatology.

[16]  S. Katz,et al.  Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options , 2006, Circulation.

[17]  S. Anker,et al.  Anemia in chronic heart failure--frequency and prognostic impact. , 2003, Clinical nephrology.

[18]  L. Lund,et al.  Hemodilution Is Common in Patients With Advanced Heart Failure , 2003, Circulation.

[19]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[20]  D. Schwartz,et al.  The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  B. Astor,et al.  Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). , 2002, Archives of internal medicine.

[22]  G. Fonarow,et al.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.

[23]  P. Hinton,et al.  Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. , 2002, The American journal of clinical nutrition.

[24]  W. Rand,et al.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[25]  I. Shapira,et al.  The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.

[26]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[27]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[28]  T. Pearson,et al.  The classification and diagnostic criteria of the erythrocytoses (polycythaemias) , 1999, Clinical and laboratory haematology.

[29]  A. Bohm,et al.  Unidirectional upregulation of the synthesis of the major iron proteins, transferrin-receptor and ferritin, in HepG2 cells by the acute-phase protein alpha1-antitrypsin. , 1997, Journal of hepatology.

[30]  D. Silverberg,et al.  Intravenous ferric saccharate as an iron supplement in dialysis patients. , 1996, Nephron.

[31]  T. Pearson,et al.  Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology , 1995, British journal of haematology.

[32]  M. Cazzola,et al.  NEW TOOLS FOR CLINICAL EVALUATION OF ERYTHRON FUNCTION IN MAN , 1992, British journal of haematology.

[33]  H. Ochs,et al.  Iron deficiency in the rat , 1984 .

[34]  Recommended methods for measurement of red-cell and plasma volume: International Committee for Standardization in Haematology. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  J Feldschuh,et al.  Prediction of the Normal Blood Volume: Relation of Blood Volume to Body Habitus , 1977, Circulation.

[36]  R. Person,et al.  Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. , 1976, The Journal of clinical investigation.

[37]  H. I. Glass,et al.  Standard techniques for the measurement of red-cell and plasma volume. A report by the International Committee for Standardization in Hematology (ICSH): Panel on Diagnostic Applications of Radioisotopes in Haematology. , 1974, British journal of haematology.